𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Autologous stem cell transplantation for patients with chronic myeloid leukemia : The Argentine Group of Bone Marrow Transplantation (GATMO) experience

✍ Scribed by Benjamín Koziner; Cristina Dengra; Graciela Lucero; Graciela Klein; Carlos Cánepa; Vera Milovic; Gustavo Milone; Anibal Robinson; Ider Cerutti; Graciela Saporito; Gustavo Kusminsky; Jorge Milone; Javier Bordone; Francisco Lastiri


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
98 KB
Volume
95
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Background:

The objective of this analysis was to evaluate the role of autologous stem cell transplantation (asct) in prolonging disease free survival (dfs) and overall survival (os) in patients with chronic myeloid leukemia (cml) who received autografts of philadelphia chromosome (ph) positive or ph negative cell harvests.

Methods:

Over a 4-year period (1994-1999), 53 patients who underwent asct for cml were reported to the argentine group of bone marrow transplantation (gatmo) registry.

Results:

Ph negative cell products were harvested in only 18 patients (34%). comparison of disease status at the time of autograft, duration of neutropenia, thrombocytopenia, days of antibiotics, and transfusional requirements of red blood cells and platelets did not reveal statistical significant differences between the ph positive group and the ph negative group. only days of hospitalization were increased significantly in patients who received ph positive autografts. although dfs at 36 months was significantly longer after infusion of ph negative cell products (54% vs. 14%; p <or= 0.005), os differences between the ph negative group and the ph positive group (68% vs. 53%; p <or= 0.134) were not significant.

Conclusions:

Asct with ph negative cell harvests after myeloablative chemotherapy resulted in prolonged periods of hematologic and cytogenetic remission or stable disease after cytogenetic/molecular recurrence in some patients with cml. a superior dfs was observed without any benefit observed for os.


📜 SIMILAR VOLUMES


Non-random involvement of chromosome 13
✍ Andrew Chase; Julie Pickard; Richard Szydlo; Stephanie Coulthard; John M. Goldma 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

Chronic myeloid leukemia (CML) patients with persistent or relapsed disease following bone-marrow transplantation (BMT) usually show both clonal and non-clonal cytogenetic changes in addition to the Philadelphia (Ph) translocation. These changes are presumably due to conditioning prior to transplant